Login / Signup

Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration.

Jinbin XuHuifangjie L FarsadYiran HouKia BarclayBen Anthony LopezShinnosuke YamadaIbrahim Olabayode SaliuYiming ShiWilliam C KnightRandell J BatemanTammie L S BenzingerJason J YiQingyun LiTing WangJoel S PerlmutterJohn C MorrisGuoyan Zhao
Published in: Nature aging (2023)
The commonalities and differences in cell-type-specific pathways that lead to Alzheimer disease (AD) and Parkinson disease (PD) remain unknown. Here, we performed a single-nucleus transcriptome comparison of control, AD and PD striata. We describe three astrocyte subpopulations shared across different brain regions and evolutionarily conserved between humans and mice. We reveal common features between AD and PD astrocytes and regional differences that contribute toward amyloid pathology and neurodegeneration. In contrast, we found that transcriptomic changes in microglia are largely unique to each disorder. Our analysis identified a population of activated microglia that shared molecular signatures with murine disease-associated microglia (DAM) as well as disease-associated and regional differences in microglia transcriptomic changes linking microglia to disease-specific amyloid pathology, tauopathy and neuronal death. Finally, we delineate undescribed subpopulations of medium spiny neurons (MSNs) in the striatum and provide neuronal transcriptomic profiles suggesting disease-specific changes and selective neuronal vulnerability.
Keyphrases